Vanguard Group Inc Orgenesis Inc. Call Options Transaction History
Vanguard Group Inc
- $4.96 Trillion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding ORGS
# of Institutions
18Shares Held
1.63MCall Options Held
0Put Options Held
0-
Geode Capital Management, LLC Boston, MA288KShares$195,8090.0% of portfolio
-
Black Rock Inc. New York, NY125KShares$85,1530.0% of portfolio
-
State Street Corp Boston, MA67.7KShares$46,0080.0% of portfolio
-
Ronit Capital LLP54.2KShares$36,8330.1% of portfolio
-
Northern Trust Corp Chicago, IL40.7KShares$27,6570.0% of portfolio
About Orgenesis Inc.
- Ticker ORGS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,545,800
- Market Cap $17.4M
- Description
- Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, ...